Search Results - "Burckel, H."

Tenascin-C orchestrates radiotherapy-induced head and neck tumor regression.

Authors: Loustau T Mitrentsi I Wang N et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2026 May; Vol. 18 (5), pp. 1707-1743. Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Unraveling Uveal Melanoma: Advances in Three-Dimensional Models.

Authors: Palmeri, Nicoletta D'Amico, Agata Grazia Matera, Serena et al.

Source: Applied Sciences (2076-3417); Mar2026, Vol. 16 Issue 6, p2797, 20p

Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation.

Authors: Roy, Nilanjan Cucullo, Luca

Source: Biosensors (2079-6374); Mar2026, Vol. 16 Issue 3, p155, 37p

Patient-derived complex organoids are a critical tool to understand and explore pediatric malignant brain tumors.

Authors: Deschuyter M Martin S Salmanli C et al.

Source: Cancer metastasis reviews [Cancer Metastasis Rev] 2026 Mar 03; Vol. 45 (1). Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

Genotypic and Phenotypic Diversity as a Function of CRISPR-Directed Gene Knock-Out of NRF2 in Pancreatic Adenocarcinoma Cells, a Feasibility Study.

Authors: McGill, London P. Banas, Kelly H. Tiesi, Gregory et al.

Source: Biomolecules (2218-273X). Jun2026, Vol. 16 Issue 6, p828. 13p.

PARP Inhibitors as Radiosensitizers: Current Evidence and Future Directions.

Authors: Pereira E Pereira F Campos G et al.

Source: Current oncology reports [Curr Oncol Rep] 2026 Jun 01; Vol. 28 (1). Date of Electronic Publication: 2026 Jun 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

The neglected burden of chronic hypoxia on the resistance of glioblastoma multiforme to first-line therapies.

Authors: Bou-Gharios J Noël G Burckel H

Source: BMC biology [BMC Biol] 2024 Nov 28; Vol. 22 (1), pp. 278. Date of Electronic Publication: 2024 Nov 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190720 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7007 (Electronic) Linking ISSN: 17417007 NLM ISO Abbreviation: BMC Biol Subsets: MEDLINE

Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors—Preclinical Evidence.

Authors: Salazar-Vilches, Cristian J. Ebner, Daniel K. Kloeber, Jake A. et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p682. 18p.

Advancing the Study of Glioblastoma Through 3D Tumor Models.

Authors: Salmeron-Moreno, Karen Buclez, Josephine Kim, Chris Donghyun et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p668. 19p.

Engineering Resilience: How Irradiation Strategies Influence 3D-Bioprinted Adipose Stem Cells.

Authors: Amiri, Nicki Schmid, Rafael Schrüfer, Stefan et al.

Source: Bioengineering (Basel). Jan2026, Vol. 13 Issue 1, p25. 19p.

Radiosensitization by Docetaxel Prodrug-Loaded Lipid Nanoparticles in Pancreatic Cancer Xenografts.

Authors: Alhussan, Abdulaziz Jackson, Nolan Dos Santos, Nancy et al.

Source: Nanomaterials (2079-4991). Oct2025, Vol. 15 Issue 19, p1521. 11p.

Subjects: Pancreatic cancer, Radiotherapy, Radiation-sensitizing agents, Cancer treatment, Xenografts, Nanocarriers

Remodelling the tumour microenvironment and beyond: ERO1A as a multifaceted regulator and emerging therapeutic target in cancer.

Authors: Mao, Jing Wang, Kai

Source: Clinical & Translational Medicine. Jul2026, Vol. 16 Issue 7, p1-20. 20p.

Advances in Modeling Multiple Myeloma Within the Bone Marrow Tumor Microenvironment for Exploration of Current and Emerging Therapies.

Authors: Toomes, Charlotte E. J. Best, Oliver G. Hollenberg, Timothy et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2050. 35p.

Metabolism and Immunity-Adapted Radiotherapy (M.I.A.R): A Conceptual Framework for Overcoming the Therapeutic Plateau in Clinical Radiotherapy.

Authors: Maravelis, Georgios Koukourakis, Ioannis M. Skarlos, Pantelis et al.

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p364. 29p.

Synergistic Effects of Cryotherapy and Radiotherapy in Glioblastoma Treatment: Evidence from a Murine Model.

Authors: Cebula, Hélène Po, Chrystelle Mura, Carole et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1692. 16p.

Utilization of All-Chitin Composite Films for High-Density Three-Dimensional Cell Cultivation.

Authors: Totani, Masayasu Eda, Mako Shinchi, Hiroyuki et al.

Source: Molecules. Nov2025, Vol. 30 Issue 21, p4243. 11p.

Current application status of proton beam therapy for gastrointestinal tumors.

Authors: Zhang, Jingwen Zhou, Han Zhao, Benxin et al.

Source: Oncologie (De Gruyter). Nov2025, Vol. 27 Issue 6, p855-866. 12p.

From monolayer to spheroid: assessing influenza a virus infection in 2D and 3D cell culture of A549 and HEK293.

Authors: Shokouhi, Hadiseh Gholizadeh, Fatemeh Sokhandan, Hosnieh et al.

Source: Virology Journal. 9/29/2025, Vol. 22 Issue 1, p1-12. 12p.

Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancer.

Authors: Burckel H Nicol A Mura C et al.

Source: Journal of translational medicine [J Transl Med] 2025 Mar 23; Vol. 23 (1), pp. 360. Date of Electronic Publication: 2025 Mar 23.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo.

Authors: Zhu, Haixin Shen, Minmin Zhu, Yiqian et al.

Source: Cancer Cell International. 8/26/2025, Vol. 25 Issue 1, p1-11. 11p.